Results 211 to 220 of about 262,864 (261)

Cholesterol synthesis in cholesteatoma.

Ear Research Japan, 1990
Sugita, Takafumi, Hayashi, Narihiko, Honda, Yoshio   +2 more
openaire   +1 more source

Corrigendum to “NUDT21‐mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression”

Advanced Science, EarlyView.
wiley   +1 more source

Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis

Ionescu R, Nicaise AM, Reisz JA, Williams EC, Prasad P, Dzieciatkowska M, Stephenson D, Cubero MS, Pirvan L, Willis CM, Peruzzotti-Jametti L, Fossati V, Edenhofer F, Leonardi T, Frezza C, Mohorianu I, D’Alessandro A, Pluchino S.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Towards the Synthesis of Cholesterol

Nature, 1947
NO development of organic chemistry or of biochemistry has unfolded in a more dramatic manner in recent years than that concerned with the nature and functions of the steroids, the bile acids, and the related vitamins and hormones.
J W, CORNFORTH, R, ROBINSON
openaire   +2 more sources

THE SYNTHESIS OF CHOLESTEROL GLUCOPYRANOSIDURONATE

Canadian Journal of Biochemistry, 1966
Cholesterol glucopyranosiduronate was synthesized by the hydrolysis of cholesterol methyl triacetyl glucopyranosiduronate with barium hydroxide under mild conditions. Some of its properties were investigated.
F, Nagayama, A, Saito, D R, Idler
openaire   +2 more sources

Tamoxifen decreases serum cholesterol by inhibiting cholesterol synthesis

Atherosclerosis, 1992
Helena Gylling, T A Miettinen, E Mantyla   +2 more
exaly   +3 more sources

Dietary cholesterol, membrane cholesterol and cholesterol synthesis

Biochimie, 1991
After describing the main steps of cholesterol biosynthesis the author recalls that the cholesterogenesis rate is feedback-inhibited by dietary cholesterol and examines the various processes of modulation. Hydroxy-3-methylglutaryl (HMG) CoA reductase, the key rate-limiting enzyme, is a 97 kDa endoplasmic reticulum glycoprotein, anchored 7-fold in this ...
openaire   +2 more sources

Cholesterol Synthesis Inhibitors in Cholesterol Gallstone Disease

Scandinavian Journal of Gastroenterology, 1996
Cholesterol synthesis inhibitors (HMG-CoA Reductase Inhibitors) are reported to decrease cholesterol saturation index of duodenal bile in hypercholesterolaemic subjects. The dissolution of gallstones in animals on treatment with these drugs created expectations of a therapeutical role for these drugs in cholesterol gallstone disease.
J W, Smit, K J, VanErpecum, G P, VanBerge-Henegouwen   +2 more
openaire   +2 more sources